September 18, 2017
A California federal judge agreed Monday to transfer to New Jersey a proposed class action accusing drugmaker Novo Nordisk Inc. and pharmacy benefit manager OptumRx Inc. of conspiring to drive up the price of Novo Nordisk's diabetes drug Victoza, noting that five suits over similar schemes have already been filed in New Jersey federal court.
August 08, 2017
Novo Nordisk Inc. and pharmacy benefits manager OptumRx Inc. on Monday urged a California federal judge to transfer the putative class action accusing them of inflating prices for a diabetes medication to New Jersey, where five nearly identical suits are already pending.
May 24, 2017
Drugmaker Novo Nordisk Inc. and pharmacy benefit manager OptumRx Inc. have conspired to artificially inflate the price of a Type 2 diabetes medication, forcing patients to pay more than they normally would for the treatment, according to a proposed class action filed Tuesday in California federal court.